What is SelectQuote?
SelectQuote operates as a pivotal player in the InsurTech landscape, having pioneered a model that provides consumers with unbiased comparisons from highly-rated insurance providers. The company's value proposition is anchored in a dual-engine approach: a consultative sales force supported by proprietary lead-routing technology. This ecosystem allows SelectQuote to effectively navigate the complexities of the Medicare market, chronic care management, and life insurance distribution. By integrating pharmacy services and virtual care into its core offerings, the firm has evolved from a simple lead-generation platform into a comprehensive healthcare services provider, positioning itself as an essential intermediary in the consumer insurance journey.
How much funding has SelectQuote raised?
SelectQuote has raised a total of $675M across 2 funding rounds:
Other Financing Round
$350M
Debt
$325M
Other Financing Round (2025): $350M with participation from Bain Capital and MORGAN STANLEY
Debt (2026): $325M led by Pathlight Capital
Key Investors in SelectQuote
Bain Capital
A leading global private investment firm that provides flexible capital solutions and deep sector expertise to support companies through complex strategic and operational transitions.
MORGAN STANLEY
A premier global financial services institution offering comprehensive investment banking, securities, and wealth management services to a diverse international client base.
Pathlight Capital
A private credit investment manager specializing in asset-based lending solutions that provide companies with the liquidity necessary for working capital, debt refinancing, and strategic growth.
What's next for SelectQuote?
With the recent influx of capital, SelectQuote is well-positioned to optimize its capital structure and accelerate its growth initiatives. The strategic focus will likely remain on deepening its penetration within the Medicare Advantage and Supplement markets, while simultaneously expanding its healthcare services footprint. By utilizing these funds to enhance its proprietary technology and operational capacity, the company aims to drive higher conversion rates and improve consumer outcomes. As the firm continues to refine its lead-generation efficiency and diversify its service offerings, it remains a critical entity for investors monitoring the intersection of healthcare and financial services. The ongoing support from institutional partners suggests a high degree of confidence in the company's ability to execute its long-term vision and maintain its competitive edge in a rapidly evolving regulatory and market environment.
See full SelectQuote company page
